J&J/Ethicon unveil new wound closure surgical devices; Covidien wins 510(k), CE mark for respiratory monitoring system;

 @FierceMedDev: Alere has reached a deal with the FDA on Dx production, looking to move past May's recall of 800K test kits. More | Follow @FierceMedDev

 @MarkHFierce: Sony may be boosting its involvement in med tech, but investors are worried the company is going down a sinkhole. More | Follow @MarkHFierce

 @DamianFierce: Medtronic's next-gen renal denervation device takes a page from the St. Jude tech Medtronic earlier dismissed. More | Follow @DamianFierce

> Johnson & Johnson ($JNJ)/Ethicon says it is rolling out new wound closure surgical devices as part of its Stratafix line. Release

> Covidien ($COV) has nailed down a 510(k) clearance and CE mark for a new bedside respiratory patient monitoring system. Release

> BioBehavioral Diagnostics has raised $1 million in new financing to help fuel marketing of its ADHD diagnostic. Story

> Penn State scientists believe they are a few steps away from creating a medical analytic device like Star Trek's tricorder, having figured out how to use acoustic waves to sort cells on a chip. Story

> Two new studies have determined that gene sequencing can lead to a quicker diagnosis of rare genetic disorders in newborns. Also, the process can determine mental retardation causes in tough cases, Bloomberg reports. Story

> Volcano Corp. ($VOLC) said it won 510(k) clearance and a CE mark to start marketing its new digital IVUS catheter for the treatment of peripheral vascular disease. Release

> Creganna-Tactx Medical, an Irish medical device outsourcer, has snatched up ABT Medical, a maker of medical balloons for a variety of medical devices made by other companies. Release

> ERBA Diagnostics has snatched up Escalon Medical's clinical diagnostics business for $6.5 million in cash. Release

Biotech News

 @FierceBiotech: Merger deal gives generic drugmaker control of troubled BioSante. More | Follow @FierceBiotech

 @JohnCFierce: 2012 Fierce 15 winner Aragon raises $50M for 509 program. That's 88M this year. More | Follow @JohnCFierce

 @RyanMFierce: BioSante goes the way of the M&A. More | Follow @RyanMFierce

> Report: Biosimilars team at Teva/Lonza slam the brakes on Rituxan knockoff. Article

> Momenta Pharma options antibody against red meat-related inflammation. Story

Pharma News

@FiercePharma: J&J's trying to block testimony from ex-FDA chief David Kessler, who calls its Risperdal marketing "deeply troubling." More | Follow @FiercePharma

> Teva yanks Wellbutrin copy after FDA says it's not equivalent to brand. News

> India nixes Pfizer's patent on cancer-fighter Sutent. Story

> Mylan sues FDA to revoke Ranbaxy's Diovan exclusivity. Report

Pharma Manufacturing News

> Merck whacking 20% of jobs at Ireland API plant. Story

> New Janssen distribution hub consolidates European supply chain. Article

Vaccines News

> Novartis vaccines unit's future hangs on Bexsero approval. Article

> NIH awards $1.38M to professor for HIV vaccine research. Item

> Merck's Gardasil earns high safety marks. Story

> Flu vaccine manufacturers face steep odds. News

And Finally... Cadence Biomedical has begun selling a medical device, inspired by horses, that's intended to help patients who have trouble walking gain more routine mobility. Story

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.